A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing Syndrome Interventions: Drug: ATR-101; Drug: Placebos Sponsor: Millendo Therapeutics, Inc. Recruiting - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cushing's Syndrome | Study